Ring Therapeutics
PrivateLast Round
Series C
Mar 9, 2023
Total Funding Raised
$253.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ring Therapeutics is a biotechnology company that develops programmable medicines utilizing a novel viral vector platform based on the human commensal virome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ring Therapeutics Comparables
Compare Ring Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 80% | |
| Senda Biosciences | 80% | |
| Vector BioPharma | 77% |
Ring Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 9, 2023 | ||||
| Series B | Jul 28, 2021 | ||||
| Series A | Dec 19, 2019 |
Ring Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series B, Series C |
| Invus Opportunities | Series C, Series B |
| CJ Investment | Series C |
| T. Rowe Price | Series C, Series B |
| Alexandria Venture Investments | Series C |
| UPMC Enterprises | Series C, Series B |
| Partners Investment | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 40% MoM, reaching 5.3K.
- May 14, 2025
New data shows successful infectivity and expression of AnelloVectors.
Ring Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ring Therapeutics's valuation, stock price, and market status.
Is Ring Therapeutics a public or private company?
Ring Therapeutics is a private company.
What is the current stock price of Ring Therapeutics?
Ring Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Ring Therapeutics worth (valuation)?
Valuation information for Ring Therapeutics is not publicly available.
Can I buy Ring Therapeutics stock?
Ring Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ring Therapeutics's last funding round?
Ring Therapeutics's most recent funding round was Series C on March 9, 2023.
Who are the main investors in Ring Therapeutics?
Key investors in Ring Therapeutics include Altitude Life Science Ventures, Flagship Pioneering.
Will Ring Therapeutics IPO soon?
No public IPO plans have been announced for Ring Therapeutics.
How can I track Ring Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ring Therapeutics's secondary market activity and sign up for updates.